UBS Group AG - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$485,256
+91.1%
54,158
+140.0%
0.00%
Q2 2023$253,901
+1421.1%
22,569
+1457.6%
0.00%
Q1 2023$16,692
-85.0%
1,449
-84.9%
0.00%
Q4 2022$110,986
+753.7%
9,576
+815.5%
0.00%
Q3 2022$13,000
+85.7%
1,046
+1.6%
0.00%
Q2 2022$7,000
-92.9%
1,030
-89.9%
0.00%
Q1 2022$98,000
+1860.0%
10,172
+2368.9%
0.00%
Q4 2021$5,000412
+1548.0%
0.00%
Q3 2021$0
-100.0%
25
-99.2%
0.00%
Q1 2021$51,000
-75.6%
3,278
-67.1%
0.00%
Q4 2020$209,0009,9600.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders